American Family Children's Hospital
Michael S. Ip, MD close
Michael S. Ip, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Michael S. Ip, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Michael S. Ip, MD, earned his medical degree at New York University and completed his residency at the University of Pittsburgh Medical Center.


Eye Care Services (Ophthalmology)

UW Health Clinics

University Station Clinic
(608) 263-7171 | (800) 323-8942 | Map

Regional Specialty Clinics

Freeport Memorial Hospital (Freeport)
(815) 599-6290 |  Map
UW Health Eye Clinic - Rockford (Rockford)
(815) 399-1141 |  Map

Hospital Affiliation(s)

University Hospital (primary)
Meriter Hospital, Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Ophthalmology and Visual Sciences

Professional Certifications and Education

Board Certification Ophthalmology
Fellowship New England Eye Center, Tufts University, Boston, MA
Residency University of Pittsburgh Medical Center, Pittsburgh, PA
Internship Lenox Hill Hospital, New York, NY
Medical School New York University School of Medicine, New York, NY, 1993

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.


Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

  • Adult and Pediatric Vitreoretinal Surgery
  • Evaluation and Treatment of Vitreoretinal Disease
  • Intravitreal Injections
  • Photocoagulation/Laser
  • Repair Detached Retina
  • Surgery for Diabetic Eye Disease

Programs & Conditions

PubMed Articles
Eadie JA Ip MS . Reply. Retina. 2016 Feb;36(2):e10-2
[PubMed ID: 26696314]
Aref AA Scott IU Oden NL Ip MS Blodi BA VanVeldhuisen PC . Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15. JAMA Ophthalmol. 2015 Sep;133(9):1022-9
[PubMed ID: 26086920]
Eadie JA Ip MS . Reply: To PMID 24999721. Retina. 2015 Aug;35(8):e54-5
[PubMed ID: 26166802]
Domalpally A Ip MS Ehrlich JS . Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials. Ophthalmology. 2015 Apr;122(4):779-86
[PubMed ID: 25601535]
Ip MS Domalpally A Sun JK Ehrlich JS . Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. Ophthalmology. 2015 Feb;122(2):367-74
[PubMed ID: 25439595]
Eadie JA Ip MS Kulkarni AD . Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab. Retina. 2014 Dec;34(12):2439-43
[PubMed ID: 24999721]
Eadie JA Ip MS Ver Hoeve JN . Localized retinal manifestations of paraneoplastic autoimmune retinopathy. Retin Cases Brief Rep. 2014 Fall;8(4):318-21
[PubMed ID: 25372537]
Eadie JA Gottlieb JL Ip MS Blodi BA Danis RP Chandra SR Nork TM Altaweel MM Stern-Hogan BS . Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct;45(5):394-7
[PubMed ID: 25230402]
Lavine JA Sang Y Wang S Ip MS Sheibani N . Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism. JAMA Ophthalmol. 2013 Mar;131(3):376-82
[PubMed ID: 23303344]
Kulkarni AD Ip MS . Diabetic macular edema: therapeutic options. Diabetes Ther. 2012 Nov;3(1):1-14
[PubMed ID: 22392532]
Ip MS Domalpally A Hopkins JJ Wong P Ehrlich JS . Long-term effects of ranibizumab on diabetic retinopathy severity and progression. Arch Ophthalmol. 2012 Sep;130(9):1145-52
[PubMed ID: 22965590]
Freisberg L Rolle TJ Ip MS . Diffuse macular edema in niacin-induced maculopathy may resolve with dosage decrease. Retin Cases Brief Rep. 2011 Summer;5(3):227-8
[PubMed ID: 25390170]
Blodi BA Domalpally A Scott IU Ip MS Oden NL Elledge J Warren K Altaweel MM Kim JE Van Veldhuisen PC . Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9. Arch Ophthalmol. 2010 Sep;128(9):1140-5
[PubMed ID: 20837797]
Domalpally A Blodi BA Scott IU Ip MS Oden NL Lauer AK VanVeldhuisen PC . The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4. Arch Ophthalmol. 2009 Nov;127(11):1461-7
[PubMed ID: 19901211]
Ip MS Oden NL Scott IU VanVeldhuisen PC Blodi BA Figueroa M Antoszyk A Elman M . SCORE Study report 3: study design and baseline characteristics. Ophthalmology. 2009 Sep;116(9):1770-1777.e1
[PubMed ID: 19619896]
Ip MS Bressler SB Antoszyk AN Flaxel CJ Kim JE Friedman SM Qin H . A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. Retina. 2008 Jul-Aug;28(7):919-30
[PubMed ID: 18698292]
Thompson MJ Ip MS . Diabetic macular edema: a review of past, present, and future therapies. Int Ophthalmol Clin. 2004 Fall;44(4):51-67
[PubMed ID: 15577564]
Ip MS Gottlieb JL Kahana A Scott IU Altaweel MM Blodi BA Gangnon RE Puliafito CA . Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol. 2004 Aug;122(8):1131-6
[PubMed ID: 15302652]
Ip MS . Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema. Diabetes Care. 2004 Jul;27(7):1794-7
[PubMed ID: 15220269]
Kilby AE Ip MS Smith ME . Subluxated/dislocated lens and hyphema as features of retinoblastoma. Retina. 2003 Dec;23(6):872-4
[PubMed ID: 14707845]